Free biotech stocks directory, pharma stocks, telemedicine stocks ...
Researchers Develop Technology To Treat Charcot-Marie-Tooth (CMT) Disease
The research team led by Professor Minseok Kim from the Department of New Biology at DGIST (President Yang Kuk) has developed a technology that can treat Charcot-Marie-Tooth (CMT) disease, an incurable hereditary disease, with electric stimulation instead of drug therapy. This technology has considerable potential for the development of an electronic medicine with minimal side effects in the future.
The core of this technology is electric stimulation that corrects the abnormal distribution of peripheral myelin protein 22 (PMP 22), the cause of the disease. The research team discovered it by conducting a series of electric stimulation experiments using a CMT disease subtype 1A (CMT1A) cell model. The study was published in the March 15 issue of the journal Biosensors and Bioelectronics.
CMT disease causes muscle atrophy, numbness, foot deformities, paralysis, and other symptoms due to the loss of myelin sheath in peripheral nerves. It is a genetic disease that affects a large number of people, with approximately 1 in 2,500 individuals affected. However, there is currently no definitive treatment for this disease.
CMT1A, a subtype of CMT disease, is among the most prevalent types of peripheral nerve damage worldwide and is caused by PMP22 overexpression in Schwann cells. PMP22 overexpression in Schwann cells causes the PMP22 protein to aggregate in the cells, ultimately leading to peripheral nerve damage.
To address PMP22 overexpression, Professor Minseok Kim's team developed a CMT1A cell model PMP22-overexpressing schwannoma cell. This team applied a high-speed electric stimulation screening platform to the cells to identify optimal stimulation conditions for effective therapeutic outcomes. This electric stimulation eliminated the PMP22 protein aggregation around the nucleus that occurs in CMT1A disease and restored the normal distribution of the PMP22 protein towards the cell membrane, similar to that of a normal Schwann cell.
In addition, the research team observed an increase in the expression of genes (e.G., MBP, MAG) that play an important role in the formation of myelin sheaths constituting a part of peripheral nerves and changes in the gene expression of transcription factors (Krox-20, Oct-6, c-Jun, and Sox10) that control myelin sheath formation, leading to the induction of myelination in the CMT1A cell model.
Professor Minseok Kim from the Department of New Biology at DGIST stated that, "The key of this study is that it is the first demonstration that electric stimulation can restore the normal distribution of PMP22, which is a major protein in CMT1A disease. We hope that new electric medicine technologies will soon be commercialized to address CMT disease that currently has no cure and causes suffering to millions of people worldwide."
More information: Aseer Intisar et al, Electroceutical approach ameliorates intracellular PMP22 aggregation and promotes pro-myelinating pathways in a CMT1A in vitro model, Biosensors and Bioelectronics (2023). DOI: 10.1016/j.Bios.2022.115055
Provided by DGIST (Daegu Gyeongbuk Institute of Science and Technology)
Citation: Researchers develop technology to treat Charcot-Marie-Tooth (CMT) disease (2023, March 31) retrieved 31 March 2023 from https://medicalxpress.Com/news/2023-03-technology-charcot-marie-tooth-cmt-disease.Html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
What Is Charcot-Marie-Tooth Disease (CMT)?
manusapon kasosod / Getty Images
Charcot-Marie-Tooth disease (CMT) is not a tooth disease. It's a genetic (inherited) nerve disease that affects the nerve health and functioning in your extremities, including your feet, legs, hands, and arms.
These nerve-signaling problems between the brain and body parts affect your sensory nerves (nerves that signal cold and hot or soft and hard) and motor functioning skills. CMT is named after the three doctors who first described the disease in 1886.
According to the National Institute of Neurological Disorders and Stroke, CMT affects an estimated 126,000 individuals in the United States and 2.6 million people worldwide. This makes it one of the most common inherited neurological disorders.
This article will explore the symptoms and causes of CMT, how to get a diagnosis, what treatment options are available to someone with CMT, prognosis or what to expect if you have CMT, and expert tips for coping with this genetic nerve disease.
manusapon kasosod / Getty Images
SymptomsSymptoms of Charcot-Marie-Tooth disease affect the legs and feet and hands and arms. They can include the following:
Muscle weakness in lower legs and foot (can cause "foot drop," difficulty lifting your foot while walking)
Structural foot differences like high arch, flat feet, and hammertoe (a toe excessively bent at the middle joint)
Loss of muscle around your hands, wrist, feet, and ankles
Numbness, discomfort, and pain including joint and muscle pain in your hands and feet
Loss of temperature sensation in hands and feet
Related:11 Common Types of Pain Scales
CausesCMT is caused by genetic mutations, which can occur in a number of ways and for a variety of reasons. In some cases, people with CMT may have inherited the genetic mutations from their biological parents. In other cases, genetic mutations can occur spontaneously during conception and then are passed down to any future biological children.
There are over 40 different genes involved in CMT. Risk factors for inheriting and passing down genetic mutations associated with CMT are unique to each individual.
Story continues
For example, in some cases only one copy of the genetic mutation from either biological parent is needed to inherit the disease. In these cases, a child with a biological parent with CMT has a 50% greater chance of inheriting the disorder.
Having a family member with CMT does increase your likelihood of inheriting the genetic mutation, but this is not the same as saying family history equals fate. Talk to a genetic specialist to determine your overall risk.
Related:What Genomic Testing Can Tell You About Health Risks
DiagnosisDiagnosis for CMT typically begins with a conversation between someone and their healthcare provider. It usually involves the following:
If you're experiencing symptoms or are feeling nervous, overwhelmed, or disorganized due to the stress of preparing for your medical appointment, you may want to consider bringing a friend or family member to take notes or bring up questions on your behalf.
Next, the healthcare provider may recommend detailed testing including:
Nerve conduction studies or electromyography (EMG) to determine if symptoms are impacting nerves, muscles, or the connection between the two.
Genetic testing with a blood test to help determine your likelihood of symptoms being from CMT
Nerve biopsy (testing a sample of the nerve) from your leg area in rare cases in which other tests were inconclusive
Learn More:What Is Genetic Testing?
ComplicationsComplications of nerve problems can occur. These include injuries from slipping or falling due to muscle weakness in legs and feet or infections in the feet that can go untreated due to a lack of typical pain sensation signaling or temperature sensations. Seeking medical treatment can help prevent complications.
TreatmentThere is no treatment that can cure CMT, however, there are ways to reduce symptoms impacting your quality of life. Options for CMT treatment include:
Physical therapy to help stretch nerves and strengthen muscles to help slow weakness, numbness
Occupational therapy to support you in exercising motor skills and adapting to daily tasks
Orthopedic devices, including wearing ankle braces, splints, or high-top boots for more ankle support
Medications for reducing sensations of pain, if needed
Related:What to Know About Telehealth for Orthopedics
CopingCoping with any kind of nerve issue that causes pain and limits your mobility is challenging not only physically, but mentally, too. Coping with CMT can include reaching out for peer and mental health support. You may want to start by visiting the Charcot-Marie-Tooth Association (CMTA) from the National Organization for Rare Diseases (NORD).
Struggling to accept a recent diagnosis is understandable and normal. Talking with a trained mental health professional may be helpful.
Read Next:Best Online Therapy Services
SummaryCharcot-Marie-Tooth Disease is a genetic condition that affects the nerves. Symptoms include weakness, pain, and sensory issues leading to challenges with motor skill functioning. While there is no cure, there are treatments that can help support a healthy life with CMT.
These include physical therapy to build strength and slow disability, occupational therapy and devices to help with mobility, and medications to reduce symptoms of pain. If interested, support groups and therapy may also help you cope with Charcot-Marie-Tooth disease.
Here's What You Need To Know About CMT Music Awards Road Closures In Austin
statesman.Com cannot provide a good user experience to your browser. To use this site and continue to benefit from our journalism and site features, please upgrade to the latest version of Chrome, Edge, Firefox or Safari.
Comments
Post a Comment